MPN
Clinical trials for MPN explained in plain language.
Never miss a new study
Get alerted when new MPN trials appear
Sign up with your email to follow new studies for MPN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Common supplement may reduce fatigue and pain in rare blood cancers
Symptom relief Recruiting nowThis study looks at whether N-Acetylcysteine (N-AC), a common supplement, can reduce symptoms like fatigue and pain in adults with myeloproliferative neoplasms (MPNs), a group of rare blood cancers. About 27 participants with essential thrombocythemia, polycythemia vera, or myelo…
Matched conditions: MPN
Phase: PHASE1, PHASE2 • Sponsor: University of California, Irvine • Aim: Symptom relief
Last updated May 17, 2026 04:17 UTC
-
New registry aims to unlock secrets of rare blood cancers
Knowledge-focused Recruiting nowThis study follows 5,000 adults with myeloproliferative neoplasms (MPNs) — rare blood cancers — to understand how symptoms change and how the disease progresses over years. Participants share their health records, insurance data, and regular surveys about how they feel. No new tr…
Matched conditions: MPN
Sponsor: MPN Research Foundation • Aim: Knowledge-focused
Last updated May 04, 2026 16:17 UTC